DSIP, or Delta Sleep-Inducing Peptide, is a small naturally occurring neuropeptide first isolated in 1974 and researched for its possible role in sleep regulation and the body's stress response. It is studied as a potential support for disrupted sleep and elevated stress, though human evidence remains limited and inconsistent. At Menscape Clinic in Bangkok, DSIP is considered only after a medical consultation, as a research-stage peptide that is not approved for any indication.
/)
Medically reviewed by Dr. Tuksaorn Suriyakan (Ping), Anti-Aging & Regenerative Medicine Physician
8 years of experience
Our solutions for Recovery & Healing
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
DSIP (Delta Sleep-Inducing Peptide) is a short chain of nine amino acids that occurs naturally in the body and was first isolated in 1974 from the blood of sleeping rabbits. Its name comes from early observations linking it to slow-wave (delta) sleep. Since then it has been investigated for possible roles in sleep regulation, the stress response, and neuroendocrine function. Despite decades of interest in peptide-medicine circles, DSIP remains a research-stage molecule: the human studies are small, old, and often contradictory, and it is not an approved medicine anywhere we are aware of. At Menscape Clinic in Bangkok we present it honestly as an experimental option, not a proven sleep treatment.
/)
DSIP is believed to act on the brain and neuroendocrine system rather than as a classic sedative. Research suggests it may influence the HPA axis (the body's central stress pathway) and interact with systems involved in sleep timing. Notably, detailed human EEG and behavioural studies did not show the kind of sedation seen with sleeping pills, which has led some researchers to propose that DSIP may support the body's own sleep mechanisms instead of forcing drowsiness. It is important to stress that the precise mechanism in humans is not fully understood and much of the supporting work is preclinical or based on small early trials.
/)
DSIP is sometimes explored by adults dealing with disrupted, non-restorative sleep or persistently high stress who want to understand experimental options alongside established approaches. It is not a first-line answer. At Menscape Clinic, our doctors begin by looking for treatable causes of poor sleep, such as sleep apnoea, low testosterone, anxiety, stimulant or alcohol use, and lifestyle factors, before any peptide is discussed. DSIP is not appropriate for everyone, and we will not consider it where evidence-based care has not first been explored. It is not suitable during pregnancy, breastfeeding, or for anyone under 18.
/)
Any consideration of DSIP at Menscape Clinic in Bangkok starts with a full medical consultation, sleep and stress history, and appropriate baseline testing. Because DSIP is not an approved medicine, it would only ever be supplied where clinically appropriate as a research-stage peptide compounded by a licensed pharmacy partner and used under medical supervision, with clear documented consent that the evidence is limited. We set realistic expectations, monitor response, and stop if there is no clear benefit. Our English-speaking team supports local and visiting international patients throughout, and we are equally comfortable recommending against DSIP when it is not the right path.
/)
Every DSIP (Delta Sleep-Inducing Peptide) protocol starts with a full medical consultation and history review.
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Follow-up consultations every four to six weeks to assess response and safety.
We frame DSIP (Delta Sleep-Inducing Peptide) as a research-stage option and prescribe only when clinically appropriate.
DSIP is not FDA approved for any medical use, and as of 2026 it remains a research-stage peptide rather than an approved medicine. It is often sold online as a research chemical labelled "not for human consumption." There has been recent regulatory movement, including a scheduled US advisory committee review in 2026, but that is not the same as approval or clearance for routine use. At Menscape Clinic we treat it strictly as experimental and only consider it under medical supervision within applicable Thai regulations.
The honest answer is that the evidence is limited and inconsistent. Some small human studies have reported modest improvements in sleep efficiency and time to fall asleep, while careful EEG studies found no classic sedative effect. There is not enough high-quality research to promise that DSIP will improve anyone's sleep, and we are careful not to overstate it.
Long-term safety has not been well established, because the human studies are small and dated and there is limited high-quality safety data. Reported side effects in research settings have generally been mild, but unregulated, unsupervised use has been linked to safety concerns. This is exactly why we only ever consider DSIP after a medical assessment, with pharmacy-grade material and ongoing monitoring, never as a self-directed product.
In the research literature DSIP has typically been given by injection. If it were ever considered appropriate for you at Menscape Clinic, the doctor would explain the specific protocol, dosing, and monitoring in person. We do not publish dosing online because it must be individualised and supervised.
Conventional sleep medications generally work by sedating the brain. DSIP appears to act differently, with research suggesting it may influence stress and sleep-regulating systems rather than forcing sedation. That distinction is based on early studies and should be seen as a research hypothesis, not a proven advantage.
It is not something we hand out on request. Any discussion of DSIP begins with a consultation where we look for and treat the underlying causes of poor sleep or high stress first. If, after that, an experimental peptide is genuinely worth discussing, our doctors will walk you through what is and is not known so you can make an informed choice. We are happy to advise against it when it is not right for you.
/)
Dr. Tuksaorn (Dr. Ping) is an anti-aging and regenerative medicine physician with over 8 years of experience, focused on evidence-based wellness and personalized health programs that combine modern medical science with individualized care.
/)
/)
/)
/)
/)